Blood glucose regulation mechanism in depressive disorder animal model during hyperglycemic states

Brain Research Bulletin

Volumn 124, Issue , 2016, Pages 116-122

  Lim, Su Min ^a   Park, Soo Hyun ^a   Sharma, Naveen ^a   Kim, Sung Su ^a   Lee, Jae Ryeong ^a   Jung, Jun Sub ^a   Suh, Hong Won ^a  

^a Hallym University   (South Korea)

Author keywords

Blood glucose; Clonidine; D glucose fed; Depression animal model; Glucocorticoid; Immobilization stress

Indexed keywords

CLONIDINE; CORTICOSTERONE; GLUCOSE; INSULIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOWN REGULATION; ELECTROENCEPHALOGRAM; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMOBILIZATION STRESS; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BLOOD; COMPLICATION; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG EFFECTS; EXERCISE; GLUCOSE TOLERANCE TEST; INSTITUTE FOR CANCER RESEARCH MOUSE; PHYSIOLOGY; PSYCHOLOGY; TIME FACTOR;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BLOOD GLUCOSE; CLONIDINE; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG ADMINISTRATION ROUTES; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN; MALE; MICE; MICE, INBRED ICR; RESTRAINT, PHYSICAL; TIME FACTORS; UP-REGULATION;

EID: 84963690424     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2016.03.014     Document Type: Article

References (32)

1. Baek I.S., Park J.Y., Han P.L. Chronic antidepressant treatment in normal mice induces anxiety and impairs stress-coping ability. Exp. Neurobiol. 2015, 24:156-168.
2. Bogner H.R., Morales K.H., Post E.P., Bruce M.L. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 2007, 30:3005-3010.
3. Brownlee Christen Depression and diabetes are fellow travelers, researchers say. JHU Gazette 2008, 37:1-2.
4. Egede L.E., Zheng D., Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002, 25:464-470.
5. Fagerholm V., Haaparanta M., Scheinin M. alpha2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin. Pharmacol. Toxicol. 2011, 108:365-370.
6. Gendelman N., Snell-Bergeon J.K., McFann K., Kinney G., Paul Wadwa R., Bishop F., Rewers M., Maahs D.M. Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care 2009, 32:575-579.
7. Glick D., Vonredlich D., Levine S. Fluorometric determination of corticosterone and cortisol in 0.02-0.05 milliliters of plasma or submilligram samples of adrenal tissue. Endocrinology 1964, 74:653-655.
8. Gunn B.G., Brown A.R., Lambert J.J., Belelli D. Neurosteroids and GABA(A) Receptor Interactions: a Focus on Stress. Front. Neurosci. 2011, 5:131.
9. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 1957, 12:12-15.
10. Hylden J.L., Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res. 1981, 217:212-215.
11. Ito N., Ito T., Kromminga A., Bettermann A., Takigawa M., Kees F., Straub R.H., Paus R. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J. 2005, 19:1332-1334.
12. Jansen A.S., Nguyen X.V., Karpitskiy V., Mettenleiter T.C., Loewy A.D. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 1995, 270:644-646.
13. Kalantaridou S.N., Zoumakis E., Makrigiannakis A., Lavasidis L.G., Vrekoussis T., Chrousos G.P. Corticotropin-releasing hormone, stress and human reproduction: an update. J. Reprod. Immunol. 2010, 85:33-39.
14. Koponen H., Kautiainen H., Leppanen E., Mantyselka P., Vanhala M. Association between suicidal behaviour and impaired glucose metabolism in depressive disorders. BMC Psychiatry 2015, 15:163.
15. Kudielka B.M., Wust S. Human models in acute and chronic stress: assessing determinants of individual hypothalamus-pituitary-adrenal axis activity and reactivity. Stress 2010, 13:1-14.
16. Lustman P.J., Clouse R.E. Depression in diabetic patients: the relationship between mood and glycemic control. J. Diabetes Complications 2005, 19:113-122.
17. Magarinos A.M., Verdugo J.M., McEwen B.S. Chronic stress alters synaptic terminal structure in hippocampus. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14002-14008.
18. Mazzon E., Cuzzocrea S. Role of TNF-alpha in ileum tight junction alteration in mouse model of restraint stress. Am. J. Physiol. Gastrointestinal Liver Physiol. 2008, 294:G1268-1280.
19. Nouwen A., Nefs G., Caramlau I., Connock M., Winkley K., Lloyd C.E., Peyrot M., Pouwer F. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 2011, 34:752-762.
20. Park J.Y., Kim T.K., Choi J., Lee J.E., Kim H., Lee E.H., Han P.L. Implementation of a two-dimensional behavior matrix to distinguish individuals with differential depression states in a rodent model of depression. Exp. Neurobiol. 2014, 23:215-223.
21. Pompili M., Lester D., Innamorati M., De Pisa E., Amore M., Ferrara C., Tatarelli R., Girardi P. Quality of life and suicide risk in patients with diabetes mellitus. Psychosomatics 2009, 50:16-23.
22. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
23. Rodin G., Voshart K. Depression in the medically ill: an overview. Am. J. Psychiatry 1986, 143:696-705.
24. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 2000, 57:925-935.
25. Seo J.S., Park J.Y., Choi J., Kim T.K., Shin J.H., Lee J.K., Han P.L. NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J. Neurosci. 2012, 32:9690-9699.
26. Sim Y.B., Park S.H., Kim S.S., Lim S.M., Jung J.S., Suh H.W. Activation of spinal alpha2 adrenergic receptors induces hyperglycemia in mouse though activating sympathetic outflow. Eur. J. Pharmacol. 2014, 741:316-322.
27. Sim Y.B., Park S.H., Kim S.S., Lim S.M., Jung J.S., Suh H.W. The modulatory role of alpha-melanocyte stimulating hormone administered spinally in the regulation of blood glucose level in -glucose-fed and restraint stress mouse models. Neuropeptides 2014, 48:207-212.
28. Suh H.W., Song D.K., Huh S.O., Kim Y.H. Involvement of dynorphin in immobilization stress-induced antinociception in the mouse. Eur. Neuropsychopharmacol. 2000, 10:407-413.
29. Surwit R.S., Schneider M.S., Feinglos M.N. Stress and diabetes mellitus. Diabetes Care 1992, 15:1413-1422.
30. Ullrich S., Wollheim C.B. Islet cyclic AMP levels are not lowered during alpha 2-adrenergic inhibition of insulin release. J. Biol. Chem. 1984, 259:4111-4115.
31. Vincent du Vigneaud W.G.K. Carbohydrate utilization, rat of disappearance of -glucose from the blood. J. Biol. Chem. 1925, 66:281-300.
32. Zacny E., Bugajski J. The effect of clonidine injected centrally on serum-free fatty acids and glucose concentration in the rat. Metab.: Clin. Exp. 1983, 32:938-942.